Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Interest Expenses (2016 - 2025)

Xtant Medical Holdings has reported Interest Expenses over the past 16 years, most recently at $718000.0 for Q4 2025.

  • Quarterly Interest Expenses fell 36.68% to $718000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, down 11.75% year-over-year, with the annual reading at $3.7 million for FY2025, 11.75% down from the prior year.
  • Interest Expenses was $718000.0 for Q4 2025 at Xtant Medical Holdings, down from $904000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $1.2 million in Q3 2024 and troughed at $1000.0 in Q1 2021.
  • The 5-year median for Interest Expenses is $739000.0 (2023), against an average of $672800.0.
  • Year-over-year, Interest Expenses tumbled 99.91% in 2021 and then skyrocketed 35800.0% in 2022.
  • A 5-year view of Interest Expenses shows it stood at $466000.0 in 2021, then increased by 6.22% to $495000.0 in 2022, then soared by 65.25% to $818000.0 in 2023, then skyrocketed by 38.63% to $1.1 million in 2024, then crashed by 36.68% to $718000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Interest Expenses are $718000.0 (Q4 2025), $904000.0 (Q3 2025), and $1.0 million (Q2 2025).